Загрузка...
Targeting PD-1/PD-L1 in lung cancer: current perspectives
Increased understanding of tumor immunology has led to the development of effective immunotherapy treatments. One of the most important advances in this field has been due to pharmacological design of antibodies against immune checkpoint inhibitors. Anti-PD-1/PD-L1 antibodies are currently in advanc...
Сохранить в:
| Опубликовано в: : | Lung Cancer (Auckl) |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217517/ https://ncbi.nlm.nih.gov/pubmed/28210151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S55176 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|